HNN3.0

Project cooperationUpdated on 8 January 2026

AI-Driven Imaging and Quantitative Phenotyping for Translational Biomedical Research

Senior Lecture (Associate Professor) at University of Strathclyde

Glasgow, United Kingdom

About

I am a faculty member in Biomedical Engineering with a research focus on the development and application of advanced imaging and AI-driven analysis methods for biomedical and translational research. My expertise spans quantitative microscopy, imaging flow cytometry, label-free imaging modalities, and deep learning approaches designed to extract interpretable, mechanistic insight rather than purely predictive outputs.

A central theme of my work is quantitative phenotyping: identifying subtle structural, morphological, and biophysical signatures associated with disease, immune response, infection, or functional state. I am particularly interested in approaches that enable scalable, reproducible analysis across large datasets and heterogeneous cohorts, including the use of explainable AI and lightweight models suitable for real-world deployment.

Within Horizon Health calls, I can contribute to projects addressing post-infection long-term conditions, vaccine development, and sex/gender differences in disease by supporting high-content cellular and tissue-level analysis, biomarker discovery, and data integration across imaging, biological, and clinical domains. I also actively engage with New Approach Methodologies (NAMs), developing AI-enabled imaging pipelines that reduce reliance on animal models while increasing biological relevance and regulatory readiness.

I am keen to collaborate with clinical, biological, and industrial partners as a methodological work-package lead or contributing partner in joint Horizon applications.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

Type

  • Partner seeks Consortium/Coordinator

Organisation

University of Strathclyde

University

Glasgow, United Kingdom

Similar opportunities